Pipeline Dermatologie

LAS 41002: Topical anti-inflammatory agent for the treatment of eczema, which is in clinical phase III in comparison studies with Ecural. LAS41002 acts on a corticosteroid receptor and its different formulations will allow treatment of different skin conditions.

LAS 41003: The combination of its anti-inflammatory and antimicrobial activity makes this topically administered product (currently in preclinical development) an interesting compound for the treatment of several types of skin infection.

LAS41004: This compound is in preclinical development, the goal is to confirm its anti-inflammatory activity and its capacity to inhibit cellular proliferation through topical administration for the treatment of psoriasis and/or atopic dermatitis.

LAS 41005: Compound with antimitotic action in affected cells combined with disintegration of keratinocytes. The product's topical activity is compared to Solaraze and to date its greater efficacy makes it potentially a drug of interest for the treatment of severe keratosis.